×
Entrez Id: 8826
Gene Symbol: IQGAP1
IQGAP1
ovarian neoplasm
0.010
AlteredExpression
LHGDN
IQGAP1 expression level seemed to be closely associated with the enhanced invasion and migration in ovarian cancer cell lines.19036171 2008
×
Entrez Id: 54940
Gene Symbol: OCIAD1
OCIAD1
ovarian neoplasm
0.010
AlteredExpression
LHGDN
This is the first report that OCIAD1 is over-expressed in metastatic ovarian cancer tissues.
18328549 2008
×
Entrez Id: 5829
Gene Symbol: PXN
PXN
ovarian neoplasm
0.010
Biomarker
LHGDN
Activation of platelet-activating factor receptor and pleiotropic effects on tyrosine phospho-EGFR/Src/FAK/paxillin in ovarian cancer .
18632638 2008
×
Entrez Id: 3698
Gene Symbol: ITIH2
ITIH2
ovarian neoplasm
0.010
Biomarker
LHGDN
Role of serum-derived hyaluronan-associated protein -hyaluronan complex in ovarian cancer .
18425383 2008
×
Entrez Id: 967
Gene Symbol: CD63
CD63
ovarian neoplasm
0.010
AlteredExpression
LHGDN
There is low expression of the proteins and mRNA of ME491 /CD63 and integrin alpha5 in ovarian cancer .
17624082 2007
×
Entrez Id: 7216
Gene Symbol: TRO
TRO
ovarian neoplasm
0.010
AlteredExpression
LHGDN
Trophinin is a potent prognostic marker of ovarian cancer involved in platinum sensitivity.17597582 2007
×
Entrez Id: 5720
Gene Symbol: PSME1
PSME1
ovarian neoplasm
0.010
Biomarker
LHGDN
Specific MALDI imaging and profiling for biomarker hunting and validation: fragment of the 11S proteasome activator complex, Reg alpha fragment, is a new potential ovary cancer biomarker.
17939699 2007
×
Entrez Id: 43
Gene Symbol: ACHE
ACHE
ovarian neoplasm
0.010
AlteredExpression
LHGDN
Both cytoplasmic ACHE and BACH2 immunostaining were significantly increased in ovarian cancer relative to benign cases.
16832351 2007
×
Entrez Id: 10481
Gene Symbol: HOXB13
HOXB13
ovarian neoplasm
0.010
Biomarker
LHGDN
Taken together, our results support a pro-proliferative and pro-survival role for HOXB13 in ovarian cancer .
17942676 2007
×
Entrez Id: 1394
Gene Symbol: CRHR1
CRHR1
ovarian neoplasm
0.010
Biomarker
LHGDN
These findings support the hypothesis that CRHR1 antagonists could potentially be used against ovarian cancer .
17667919 2007
×
Entrez Id: 144455
Gene Symbol: E2F7
E2F7
ovarian neoplasm
0.010
AlteredExpression
LHGDN
Clinical relevance of E2F family members in ovarian cancer--an evaluation in a training set of 77 patients.
17200349 2007
×
Entrez Id: 60468
Gene Symbol: BACH2
BACH2
ovarian neoplasm
0.010
AlteredExpression
LHGDN
Both cytoplasmic ACHE and BACH2 immunostaining were significantly increased in ovarian cancer relative to benign cases.
16832351 2007
×
Entrez Id: 5155
Gene Symbol: PDGFB
PDGFB
ovarian neoplasm
0.010
Biomarker
LHGDN
PDGF BB induces VEGF secretion in ovarian cancer.
18075302 2007
×
Entrez Id: 2050
Gene Symbol: EPHB4
EPHB4
ovarian neoplasm
0.010
AlteredExpression
LHGDN
Treatment of malignant, but not benign, ovarian tumour cell lines with progesterone, but not oestrogen, led to a 90% reduction in EphB4 levels that was associated with 50% reduction in cell survival.
17353927 2007
×
Entrez Id: 63928
Gene Symbol: CHP2
CHP2
ovarian neoplasm
0.010
AlteredExpression
LHGDN
The current study provides the first evidence that overexpression of the CHP2 gene affects the biological behavior of ovarian cancer cell line OVCAR3 and is one of key mechanisms for ovarian carcinoma progression, suggesting that CHP2 may be an attractive target for biological anticancer therapy.
17708351 2007
×
Entrez Id: 5605
Gene Symbol: MAP2K2
MAP2K2
ovarian neoplasm
0.010
GeneticVariation
LHGDN
Fifteen ovarian cancer cell lines, commonly used for in vitro experiments, were screened for mutations using bidirectional direct sequencing in all coding regions of BRAF, MEK1 and MEK2 .
18060073 2007
×
Entrez Id: 6286
Gene Symbol: S100P
S100P
ovarian neoplasm
0.010
AlteredExpression
LHGDN
Unfavourable prognostic significance of S100P expression in ovarian cancers.
17539915 2007
×
Entrez Id: 3640
Gene Symbol: INSL3
INSL3
ovarian neoplasm
0.010
AlteredExpression
LHGDN
Elevated plasma levels of the novel hormone INSL3 in a woman with metastatic ovarian cancer .
17549672 2007
×
Entrez Id: 1392
Gene Symbol: CRH
CRH
ovarian neoplasm
0.010
Biomarker
LHGDN
Corticotropin-releasing hormone produced by human ovarian cancer might favour survival and progression of the tumour by promoting its immune privilege.17667919 2007
×
Entrez Id: 768
Gene Symbol: CA9
CA9
ovarian neoplasm
0.010
AlteredExpression
LHGDN
MN/CA9: a potential gene marker for detection of malignant cells in effusions.
17536770 2007
×
Entrez Id: 3291
Gene Symbol: HSD11B2
HSD11B2
ovarian neoplasm
0.010
AlteredExpression
LHGDN
Type 2 11beta-hydroxysteroid dehydrogenase activity in human ovarian cancer.
17028049 2006
×
Entrez Id: 3598
Gene Symbol: IL13RA2
IL13RA2
ovarian neoplasm
0.010
AlteredExpression
LHGDN
Immunohistochemical analyses revealed that 83% of ovarian cancer specimens express IL-13Ralpha2, a high-affinity IL-13R subunit chain, whereas normal ovary samples expressed none or very low levels.
16902988 2006
×
Entrez Id: 157310
Gene Symbol: PEBP4
PEBP4
ovarian neoplasm
0.010
Biomarker
LHGDN
Anti-apoptotic hPEBP4 silencing promotes TRAIL-induced apoptosis of human ovarian cancer cells by activating ERK and JNK pathways.
16865237 2006
×
Entrez Id: 2664
Gene Symbol: GDI1
GDI1
ovarian neoplasm
0.010
AlteredExpression
LHGDN
Gene expression profiles with cDNA microarray reveal RhoGDI as a predictive marker for paclitaxel resistance in ovarian cancers.
16596196 2006
×
Entrez Id: 2706
Gene Symbol: GJB2
GJB2
ovarian neoplasm
0.010
Biomarker
LHGDN
Loss of communication in ovarian cancer.
16647893 2006